No Data
A Look At The Intrinsic Value Of Shanghai MicroPort EP MedTech Co., Ltd. (SHSE:688351)
Microelectrophysiology (688351.SH) plans to purchase real estate assets located in Zhoupu Town, Shanghai.
Microelectrophysiology (688351.SH) released an announcement that its wholly-owned subsidiary Shanghai Zidian Medical Technology Co., Ltd. (abbreviated...
Microelectrophysiology (688351.SH): Zidian Medical plans to sign a "House Sale Contract" with Shanghai Orthopedics.
On December 11, Glonghui announced that Weidian Medical (688351.SH) plans to sign a "Real Estate Purchase Contract" with Shanghai Orthopedics to purchase the ownership rights of the property located at No. 1-28, Lane 588, Tianxiong Road, Zhoupu Town, Shanghai, and the usage rights of seven underground parking spaces, for the production of catheter products and to expand its own storage space. The transaction price is based on the evaluation results provided by the asset evaluation institution and is agreed upon by negotiation to be 48.5 million yuan (excluding tax). The funds for this asset purchase will come from self-owned funds.
Third Quarter Report 2024
MicroPort (688351.SH): The net income for the first three quarters was 41.7267 million yuan, a year-on-year increase of 262.22%.
On October 21, Microport Scientific Corporation (688351.SH) announced that the company's revenue for the first three quarters was 0.291 billion yuan, a year-on-year increase of 23.21%; the net income attributable to shareholders of the listed company was 41.7267 million yuan, a year-on-year increase of 262.22%; basic earnings per share was 0.0887 yuan.
2024 Semi-Annual Report (corrected)
Shanghai MicroPort EP MedTech Co., Ltd.'s (SHSE:688351) Price In Tune With Revenues
